Placebo News and Research

RSS

Melatonin treatment does not affect insulin resistance of night shift workers

Melatonin treatment does not affect the insulin resistance or the glucose tolerance of night shift workers, according to a new study from the University of Surrey and the University Medical Centre Hamburg.

19 Feb 2024

Exercise is an effective treatment for depression, with walking, jogging, yoga, and strength training more effective than other exercises

Researchers determined the potentially most effective exercise regimen and dosage in managing major depressive disorder in comparison to antidepressants, psychotherapy, and control interventions.

16 Feb 2024

Innovative treatment increases survival of people with malignant mesothelioma, trial shows

An innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but rapidly fatal type of cancer with few effective treatment options, according to results from a clinical trial led by Queen Mary University of London.

15 Feb 2024

Daily aspirin linked to higher mortality in older adults, study finds

A study from the ASPREE clinical trial found that daily aspirin intake in adults over 70 did not increase disability-free survival and was associated with higher all-cause mortality, primarily due to cancer-related deaths.

12 Feb 2024

Blueberries boost calmness but not cognition in metabolic syndrome study

A study in the American Journal of Clinical Nutrition finds that chronic blueberry intake does not significantly improve cognitive function, alertness, or mood in adults with metabolic syndrome, despite a slight improvement in picture recognition accuracy and self-rated calmness after a high-fat, high-sugar meal.

12 Feb 2024

Stapokibart shows promise in reducing nasal congestion in seasonal allergy patients, study finds

The efficacy and safety of stapokibart as an in patients with seasonal allergic rhinitis (SAR).

9 Feb 2024

Intravenous DMT shows promise in reducing depression symptoms, study reveals

A study in Scientific Reports shows intravenous DMT can significantly reduce depression severity in healthy volunteers, highlighting its potential as a therapeutic psychedelic intervention for mental health disorders.

8 Feb 2024

Combining clot busters and blood thinners shows no advantage for people with ischemic strokes

Giving blood thinners in addition to clot-busting medications to people with ischemic strokes (clot-caused strokes) did not improve their outcomes 90 days later, according to preliminary late-breaking science presented today at the American Stroke Association's International Stroke Conference 2024.

7 Feb 2024

AMG 133 (maridebart cafraglutide) weight loss drug shows promise in early trial

AMG 133, an engineered bispecific molecule, demonstrated significant weight loss with a favorable safety profile in a phase 1 clinical trial, offering a promising new treatment option for obesity.

7 Feb 2024

AI helps predict antidepressant response in a week

In patients with major depression disorder it is, thanks to use of artificial intelligence, now possible to predict within a week whether an antidepressant will work.

7 Feb 2024

New weight loss drug may be an effective strategy for preventing or treating high blood pressure

The new weight loss medication tirzepatide significantly lowered the systolic blood pressure (the top number in a blood pressure reading) for nearly 500 adults with obesity who took the medication for about eight months, according to new research published today in Hypertension, an American Heart Association journal.

5 Feb 2024

Breakthrough obesity treatments on the horizon, rivaling surgery's success

New obesity pharmacotherapies, including GLP-1 receptor agonists and combinations of entero-pancreatic hormones, show promise in achieving significant weight loss, potentially rivaling bariatric surgery's effectiveness.

4 Feb 2024

Breakthrough gene-editing therapy transforms lives of patients with a hereditary disorder

A group of patients with a hereditary disorder have had their lives transformed by a single treatment of a breakthrough gene-editing therapy, according to the lead researcher.

2 Feb 2024

New trial explores cold-pressed castor oil as safe, natural treatment for dry-eye disease

Researchers at the University of Auckland are running a trial of castor oil as a potential safe and natural treatment for dry-eye disease following a successful pilot study.

2 Feb 2024

Gingko biloba compound injections linked to better stroke outcomes

People with ischemic (clot-caused) stroke had better early recovery of cognitive function if treated with intravenous injections of a combination of biologically active components of ginkgo biloba during the first two weeks after the stroke, according to a preliminary study to be presented at the American Stroke Association's International Stroke Conference 2024.

1 Feb 2024

Cinnamon supplements found to reduce blood glucose in prediabetics

A 12-week study shows that daily cinnamon supplements significantly lower blood glucose levels in obese and overweight prediabetic individuals, suggesting a role for the gut microbiome.

29 Jan 2024

Interventions for mood show promise for the management of IBD in improving mental health, inflammation and disease outcomes

Researchers performed a meta-analysis to explore the impact of mood interventions on inflammatory disease activity in inflammatory bowel disease (IBD).

29 Jan 2024

Placebo News and Research

Melatonin treatment does not affect insulin resistance of night shift workers

Exercise is an effective treatment for depression, with walking, jogging, yoga, and strength training more effective than other exercises

Innovative treatment increases survival of people with malignant mesothelioma, trial shows

Daily aspirin linked to higher mortality in older adults, study finds

Blueberries boost calmness but not cognition in metabolic syndrome study

Stapokibart shows promise in reducing nasal congestion in seasonal allergy patients, study finds

Intravenous DMT shows promise in reducing depression symptoms, study reveals

Combining clot busters and blood thinners shows no advantage for people with ischemic strokes

AMG 133 (maridebart cafraglutide) weight loss drug shows promise in early trial

AI helps predict antidepressant response in a week

New weight loss drug may be an effective strategy for preventing or treating high blood pressure

Breakthrough obesity treatments on the horizon, rivaling surgery's success

Breakthrough gene-editing therapy transforms lives of patients with a hereditary disorder

New trial explores cold-pressed castor oil as safe, natural treatment for dry-eye disease

Gingko biloba compound injections linked to better stroke outcomes

Cinnamon supplements found to reduce blood glucose in prediabetics

Interventions for mood show promise for the management of IBD in improving mental health, inflammation and disease outcomes

Immunotherapy drug extends overall survival in kidney cancer patients after surgery

Unbiased assessment of vamorolone for treating Duchenne muscular dystrophy

Kiwifruit improves vitality and mood in as little as four days

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News